AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Betmiga 25mg Tablet

Prescription Icon
Prescription Required

Marketer

Astellas Pharma Inc

Salt Composition

Mirabegron (25mg)

Overview Betmiga 25mg Tablet

Mirabegron 25mg tablets alleviate overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Dosage and duration should strictly adhere to your physician's instructions. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report any persistent or bothersome side effects immediately to your doctor. Prior to commencing treatment, disclose all current medications and any pre-existing health conditions, including pregnancy or breastfeeding. Individuals with hepatic or renal impairment require careful monitoring and regular follow-up appointments as directed by their healthcare provider.

Uses of Betmiga 25mg Tablet

Managing overactive bladder (OAB) symptoms

Major Benefits of Betmiga 25mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Betmiga 25mg Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Betmiga 25mg Tablet:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Betmiga 25mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. Betmiga 25mg tablets can be administered with or without food, though consistent timing is recommended.

How Betmiga 25mg Tablet works:

Betmiga 25mg tablets stimulate beta-3 receptors in the bladder. This activation relaxes bladder muscles, thereby reducing the frequency, urgency, and incontinence of urination.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Betmiga 25mg tablets with alcohol. Seek your physician's advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Betmiga 25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Betmiga 25mg tablets while breastfeeding is likely inadvisable. Scant evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Betmiga 25mg tablets.

KidneyKidneyCAUTION

Individuals with severe kidney impairment should use Mirabegron 25mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Caution is advised when prescribing Betmiga 25mg tablets to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Betmiga 25mg tablets are contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Betmiga 25mg Tablet :

Should you forget a Betmiga 25mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing schedule. Never take a double dose.

Facts to Know About Betmiga 25mg Tablet

LabelValue
Chemical Category Anilide-based Compound
Developing Habits No.
Treatment Category Urological Care
Actions Beta-3 agonist for bladder control

FAQs on Betmiga 25mg Tablet

Complete benefits from Betmiga 25mg Tablet may appear after eight weeks or more of treatment. The dosage may be adjusted after four to eight weeks, depending on individual response.
Continue taking your Betmiga 25mg Tablet even if your symptoms improve. This medication treats overactive bladder symptoms—urgency, frequent urination, and incontinence—but doesn't cure the condition. Stopping treatment could cause your symptoms to return.
Betmiga 25mg Tablets shouldn't interfere with your sleep. However, discuss any sleep issues with your doctor.
Betmiga 25mg Tablets are not recommended for children under 18 due to a lack of studied safety and efficacy data in this age group.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not cures it. Intermittent use prevents your bladder from adapting, leading to ineffective treatment and symptom recurrence.
Betmiga 25mg Tablet may cause urinary tract infections (kidneys, ureters, bladder, or urethra), though this is not universal. Renal stones and bladder pain are rare side effects. Patients with impaired kidney function should use caution and report any kidney-related symptoms to their doctor.
Caution is advised when taking Betmiga 25mg Tablet if you have high blood pressure. Regular blood pressure monitoring is recommended, as Betmiga 25mg Tablet may elevate blood pressure in some individuals. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, even without symptoms. A Betmiga 25mg Tablet overdose can elevate heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Betmiga 25mg Tablet
592
MRP 685
13% off